BioAtla, Inc. (BCAB): Insider Trading, Congress Trades & Research | Tormere

BCAB

$2.00+0.00%visit website

BioAtla, Inc.

Market Cap

$3M

Live price × SEC shares (Aug 10, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.51

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	9,539	7,995	4,582	3,342	25,458
Total operating expenses	13,789	11,255	9,308	6,273	40,625
Operating income	(13,789)	(9,255)	(9,308)	227	(32,125)
Net income	(15,778)	(9,784)	(6,344)	452	(31,454)
EPS (basic) ($)	(13.50)		(4.22)	0.27	—
EPS (diluted) ($)	(13.50)		(4.22)	0.27	—
Weighted avg. shares (basic)	1,175		1,502	1,661
Weighted avg. shares (diluted)	1,175		1,502	1,662

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 22 more quarters, back to Mar 2020, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

BioAtla, Inc. SEC Filing (Oct 30, 2026)

Stock Titan · 2026-10-30

BioAtla, Inc. SEC Filing (Oct 27, 2026)

Stock Titan · 2026-10-27

Bioatla Inc (OTC: BCAB) Share Price, BCAB Stock News, BCAB Share Price & Updates

Kalkine · 2026-09-29

BioAtla (OTCPK:BCAB) - Stock Analysis

Simply Wall St · 2026-09-01

BCAB Stock Price and Chart — OTC:BCAB

TradingView · 2026-08-31

BioAtla Received Notice of Delisting

TradingView · 2026-08-28

Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202

Yahoo Finance · 2026-05-18

BioAtla Announces Share Consolidation

Yahoo Finance · 2026-03-31

BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Yahoo Finance · 2026-03-31

BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets

Yahoo Finance · 2026-03-02

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Yahoo Finance · 2025-12-31

BioAtla Stock Slips Premarket After Early Pop As Investors Weigh $40M SPV Deal For Phase 3 Cancer Trial

Stocktwits · 2025-12-31

BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing

Yahoo Finance · 2025-11-21

BioAtla Inc (BCAB) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Promising Trial ...

Yahoo Finance · 2025-11-14

BioAtla (BCAB) Q3 2025 Earnings Call Transcript

Yahoo Finance · 2025-11-13

Informational purposes only, not investment advice.